Bribery Alleged in Largest Antidepressant Study Ever Conducted


A 2011 whistleblower complaint that was unsealed on January 20 of this year alleges that Forest Pharmaceuticals bribed a principle investigator of the STAR*D (Sequenced Treatment to Relieve Depression) study to fix the results in favor of the company’s drug Celexa. The complaint alleges that because of this bribe, Celexa was the only antidepressant employed in the first part of the study, and also led to falsification and overstatement of the drug’s effectiveness. The whistleblower is Ed Pigott, who has blogged on the STAR*D trial for
Read more
                                            Discuss →


Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.


Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.

Previous articleBring in the Peer!
Next articleAdverse Childhood Events Contribute Significantly to Most Mental Health Problems
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].